Skip to main content
. 2020 Jul 25;25(11):e1640–e1649. doi: 10.1634/theoncologist.2020-0519
All Cycles
Name NC/NA 1 2 3 4 5 All grades
Fatigue 42% 35% 19% 4% 0% 0% 58%
Cough 61% 35% 4% 0% 0% 0% 39%
Weight loss 92% 0% 8% 0% 0% 0% 8%
Nausea 88% 4% 8% 0% 0% 0% 12%
Diarrhea 88% 8% 0% 4% 0% 0% 12%
Proteinuria 88% 12% 0% 0% 0% 0% 12%
Chest pain—cardiac 88% 12% 0% 0% 0% 0% 12%
Hypertension 80% 8% 8% 4% 0% 0% 20%
Febrile neutropenia 77% 15% 4% 0% 4% 0% 23%
Mucositis oral 92% 4% 4% 0% 0% 0% 8%
Lung infection 96% 4% 0% 0% 0% 0% 4%
Bone marrow hypocellular 92% 4% 0% 4% 0% 0% 8%
Hypoalbuminemia 96% 0% 4% 0% 0% 0% 4%
Hepatic infection 92% 8% 0% 0% 0% 0% 8%
Aspiration 84% 12% 4% 0% 0% 0% 16%
Skin and subcutaneous tissue disorders—hand‐foot skin reaction 62% 23% 0% 15% 0% 0% 38%
Rash maculo‐papular 92% 8% 0% 0% 0% 0% 8%

Abbreviation: NC/NA, no change from baseline/no adverse event.